Dehydroevodiamine (hydrochloride)

• UNSPSC Description:

  Dehydroevodiamine hydrochloride is isolated from the leaves of Evodia rutaecarpa[1].

• Target Antigen:

  COX; NF-κB; NO Synthase; PGE synthase

• Type:

  Natural Products

• Related Pathways:

  Immunology/Inflammation;NF-κB

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/dehydroevodiamine-hydrochloride.html

• Purity:

  99.93

• Solubility:

  DMSO : 12.5 mg/mL (ultrasonic)|H2O : 1.43 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  O=C1N2C(N(C)C3=C1C=CC=C3)=C4C(CC2)=C5C=CC=CC5=N4.[H]Cl

• Molecular Weight:

  337.80

• References & Citations:

  [1]Haji A, et al. Increased feline cerebral blood flow induced by dehydroevodiamine hydrochloride from Evodia rutaecarpa. J Nat Prod. 1994 Mar;57(3):387-9.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Clinical Information:

  No Development Reported

• CAS Number:

  111664-82-5